Home News & Events Events Events Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any -IndustryWebinarsWorkshop Previous 1 2 In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related Information Webpage Webinars Webpage Industry Events Webpage Workshops What’s happening in ICON ICON Plc ICON reports third quarter 2025 results. Quarter three revenue was $2,042.8 million representing an increase of 1.3% on quarter two 2025. Net business wins in the quarter of $2,086 million, representing an increase of 1.... 22h View post View webpage ICON Plc USP compounding may be fast — but is it costing you quality, compliance, and insight? Join our webinar to learn why GMP is the smarter choice for early phase trials. During this session we will discuss: • The differences... 22 Oct 1 View post View webpage ICON Plc Join ICON at #CPHIFrankfurt, taking place from 28 to 30 October at Messe Frankfurt to discover how our Accelerated Pharmaceutical Solutions are built to meet the demands of a fast-moving industry—combining global reach, ... 22 Oct 2 View post View webpage ICON Plc ICON is proud to sponsor the World Drug Safety Congress, 4–6 November in Boston, MA. As a global leader in pharmacovigilance, ICON partners with biopharma and medical device companies of all sizes to strengthen patient ... 22 Oct 1 View post View webpage ICON Plc Are you going to CPHI? If so come along to our VIP in-person event on Tuesday 28th October where our panel of industry experts will discuss the challenges around accelerating timelines and reducing costs in early clinica... 22 Oct 3 View post View webpage ICON Plc By integrating drug substance, formulation development, real-time manufacturing, and clinical testing, we streamline the entire process—cutting up to 12+ months in development time and significantly reducing costs. Del... 22 Oct 4 View post View webpage ICON Plc As we begin Day Two of #OCTNordics, we’d like to take a moment to thank everyone who visited the ICON booth yesterday. It’s been a pleasure connecting with industry peers and discussing how ICON is driving innovation acr... 22 Oct View post View webpage ICON Plc ICON is hosting a webinar on 28 October at 2:00 PM KST to introduce its Strategic Solutions Functional Service Provider (FSP) services and how this model is designed to support sponsors in Korea. The session will provi... 22 Oct View post View webpage ICON Plc Join ICON at ISPOR Europe 2025 – Booth 824! From health economics and outcomes research (HEOR) to real-world evidence and market access, ICON partners with you to deliver patient-centred solutions that drive value and a... 21 Oct View post View webpage ICON Plc A survey of obesity developers suggested many multi-indication assets are being developed with trial designs intended for single-indications. Are your development strategies adapted to a multi-indication landscape? Find ... 21 Oct 2 View post View webpage ICON Plc Sponsors of multi-indication therapies often face the challenge of reconciling regulatory mandates with clinically meaningful outcomes. ICON’s Simon Bruce and Jack Martin discuss trial design considerations for drugs wit... 21 Oct View post View webpage ICON Plc In this new blog series, we review ISO 14971 (Application of risk management to medical devices) - its history, the principles embedded within it and how it relates to other standards and regulation. For the first editio... 21 Oct 2 View post View webpage
